injectible bpc 157 BPC-157 (10mg) – Alpha BioMed bpc 157 subq injection bpc
Description
NNMT interacts with nicotinamide metabolism, leading researchers to investigate potential downstream effects on NAD availability

Rare but serious risks include pancreatitis, gallbladder disease, hypoglycemia, allergic reaction, and a specific thyroid tumor signal

The desensitization process is carried out according to a protocol that assumes a gradual increase in the drug dose until a therapeutic dose is reached, which is simultaneously associated with a gradual increase in the threshold concentration (which would cause anaphylaxis)

The NHS route is for people with a clinically confirmed B12 deficiency
